OBJECTIVES: Pulse wave analysis is widely applied to measure the haemodynamic effects of nitroglycerin and salbutamol as an endothelium-independent and endothelium-dependent vasodilator, respectively. The recordings are usually performed in supine position from 10 to 20 successive heartbeats without simultaneous measurement of vascular resistance and cardiac function. Our objective was to examine the effects of nitroglycerin and salbutamol on central haemodynamics, arterial stiffness, cardiac function, and vascular resistance in supine and upright positions. METHODS: A placebo-controlled, randomized and double-blinded passive head-up tilt protocol was performed after sublingual nitroglycerin (0.25 mg) or inhaled salbutamol (400 μg) in 35 healthy volunteers. Continuous tonometric pulse wave analysis, whole-body impedance cardiography, and plethysmographic finger blood pressure recordings were applied. RESULTS:Nitroglycerin decreased aortic and finger blood pressure, radial DBP, vascular resistance, augmentation index and pulse wave velocity, and increased heart rate, cardiac index, stroke index and aortic reflection time (P < 0.030 for all). Salbutamol moderately decreased radial and aortic blood pressure and finger DBP, augmentation index and vascular resistance, but increased heart rate and cardiac index (P < 0.030 for all). Almost all of the strong haemodynamic effects of nitroglycerin were emphasized during the head-up tilt, whereas the effects of salbutamol on heart rate and cardiac index were more pronounced in the supine position. CONCLUSION: The haemodynamic changes induced by nitroglycerin and salbutamol were dependent on body position: the effects of nitroglycerin were accentuated during the head-up tilt, whereas those of salbutamol were more evident in the supine position.
RCT Entities:
OBJECTIVES: Pulse wave analysis is widely applied to measure the haemodynamic effects of nitroglycerin and salbutamol as an endothelium-independent and endothelium-dependent vasodilator, respectively. The recordings are usually performed in supine position from 10 to 20 successive heartbeats without simultaneous measurement of vascular resistance and cardiac function. Our objective was to examine the effects of nitroglycerin and salbutamol on central haemodynamics, arterial stiffness, cardiac function, and vascular resistance in supine and upright positions. METHODS: A placebo-controlled, randomized and double-blinded passive head-up tilt protocol was performed after sublingual nitroglycerin (0.25 mg) or inhaled salbutamol (400 μg) in 35 healthy volunteers. Continuous tonometric pulse wave analysis, whole-body impedance cardiography, and plethysmographic finger blood pressure recordings were applied. RESULTS:Nitroglycerin decreased aortic and finger blood pressure, radial DBP, vascular resistance, augmentation index and pulse wave velocity, and increased heart rate, cardiac index, stroke index and aortic reflection time (P < 0.030 for all). Salbutamol moderately decreased radial and aortic blood pressure and finger DBP, augmentation index and vascular resistance, but increased heart rate and cardiac index (P < 0.030 for all). Almost all of the strong haemodynamic effects of nitroglycerin were emphasized during the head-up tilt, whereas the effects of salbutamol on heart rate and cardiac index were more pronounced in the supine position. CONCLUSION: The haemodynamic changes induced by nitroglycerin and salbutamol were dependent on body position: the effects of nitroglycerin were accentuated during the head-up tilt, whereas those of salbutamol were more evident in the supine position.
Authors: D Vrachatis; T G Papaioannou; A Konstantopoulou; E G Nasothimiou; S Millasseau; J Blacher; M E Safar; P P Sfikakis; G S Stergiou; A D Protogerou Journal: J Hum Hypertens Date: 2013-10-24 Impact factor: 3.012
Authors: Miia H Leskinen; Elina J Hautaniemi; Anna M Tahvanainen; Jenni K Koskela; Marika Päällysaho; Antti J Tikkakoski; Mika Kähönen; Tiit Kööbi; Onni Niemelä; Jukka Mustonen; Ilkka H Pörsti Journal: PLoS One Date: 2014-08-25 Impact factor: 3.240
Authors: Pauliina Kangas; Anna Tahvanainen; Antti Tikkakoski; Jenni Koskela; Marko Uitto; Jari Viik; Mika Kähönen; Tiit Kööbi; Jukka Mustonen; Ilkka Pörsti Journal: J Am Heart Assoc Date: 2016-06-21 Impact factor: 5.501
Authors: Willebrordus Pj van Oosterhout; Guus G Schoonman; Dirk P Saal; Roland D Thijs; Michel D Ferrari; J Gert van Dijk Journal: Cephalalgia Date: 2019-10-09 Impact factor: 6.292
Authors: Jenni K Koskela; Anna Tahvanainen; Antti Haring; Antti J Tikkakoski; Erkki Ilveskoski; Jani Viitala; Miia H Leskinen; Terho Lehtimäki; Mika Ap Kähönen; Tiit Kööbi; Onni Niemelä; Jukka T Mustonen; Ilkka H Pörsti Journal: BMC Cardiovasc Disord Date: 2013-11-15 Impact factor: 2.298
Authors: Anna M Tahvanainen; Antti J Tikkakoski; Jenni K Koskela; Klaus Nordhausen; Jani M Viitala; Miia H Leskinen; Mika A P Kähönen; Tiit Kööbi; Marko T Uitto; Jari Viik; Jukka T Mustonen; Ilkka H Pörsti Journal: BMC Cardiovasc Disord Date: 2016-05-23 Impact factor: 2.298
Authors: Elina J Hautaniemi; Antti J Tikkakoski; Arttu Eräranta; Mika Kähönen; Esa Hämäläinen; Ursula Turpeinen; Heini Huhtala; Jukka Mustonen; Ilkka H Pörsti Journal: PLoS One Date: 2019-10-18 Impact factor: 3.240